These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30177068)

  • 1. Economic evaluation of sFlt-1/PlGF ratio test in pre-eclampsia prediction and diagnosis in two Brazilian hospitals.
    Figueira SF; Wolf C; D'Innocenzo M; de Carvalho JPV; Barbosa MG; Zlotnik E; Cordioli E
    Pregnancy Hypertens; 2018 Jul; 13():30-36. PubMed ID: 30177068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. sFlt-1/PlGF ratio test for pre-eclampsia: an economic assessment for the UK.
    Vatish M; Strunz-McKendry T; Hund M; Allegranza D; Wolf C; Smare C
    Ultrasound Obstet Gynecol; 2016 Dec; 48(6):765-771. PubMed ID: 27300726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany.
    Schlembach D; Hund M; Schroer A; Wolf C
    BMC Health Serv Res; 2018 Aug; 18(1):603. PubMed ID: 30081904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the value of the sFlt-1/PlGF ratio for the prediction of preeclampsia: Cost analysis from the Belgian healthcare payers' perspective.
    Chantraine F; Van Calsteren K; Devlieger R; Gruson D; Keirsbilck JV; Dubon Garcia A; Vandeweyer K; Gucciardo L
    Pregnancy Hypertens; 2021 Dec; 26():31-37. PubMed ID: 34482271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budget impact analysis of sFlt-1/PlGF ratio as prediction test in Italian women with suspected preeclampsia.
    Frusca T; Gervasi MT; Paolini D; Dionisi M; Ferre F; Cetin I
    J Matern Fetal Neonatal Med; 2017 Sep; 30(18):2166-2173. PubMed ID: 27737599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of the sFlt-1/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study.
    Ohkuchi A; Masuyama H; Yamamoto T; Kikuchi T; Taguchi N; Wolf C; Saito S
    Hypertens Res; 2021 Jul; 44(7):822-829. PubMed ID: 33594274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
    Frampton GK; Jones J; Rose M; Payne L
    Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
    Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of N-terminal pro-B natriuretic peptide to soluble fms-like tyrosine kinase-1/placental growth factor ratio > 38 improves prediction of pre-eclampsia requiring delivery within 1 week: a longitudinal cohort study.
    Sabriá E; Lequerica-Fernández P; Lafuente-Ganuza P; Eguia-Ángeles E; Escudero AI; Martínez-Morillo E; Barceló C; Álvarez FV
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):758-767. PubMed ID: 29498431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective.
    Hodel M; Blank PR; Marty P; Lapaire O
    Dis Markers; 2019; 2019():4096847. PubMed ID: 31485276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin.
    Navaratnam K; Abreu P; Clarke H; Jorgensen A; Alfirevic A; Alfirevic Z
    J Matern Fetal Neonatal Med; 2019 Jan; 32(2):179-187. PubMed ID: 28851242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rule-in and rule-out of pre-eclampsia using DELFIA Xpress PlGF 1-2-3 and sFlt-1: PlGF ratio.
    Bremner L; Gill C; Seed PT; Conti-Ramsden F; Webster L; Fleminger J; Chappell LC; Shennan A; Bramham K
    Pregnancy Hypertens; 2022 Mar; 27():96-102. PubMed ID: 34979346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam.
    Nguyen TH; Bui TC; Vo TM; Tran QM; Luu LT; Nguyen TD
    Pregnancy Hypertens; 2018 Oct; 14():37-42. PubMed ID: 30527116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of sFlt-1/PlGF ratio in preeclampsia : a monocentric retrospective analysis].
    Verbeurgt L; Chantraine F; De Marchin J; Minon JM; Nisolle M
    Rev Med Liege; 2017 Sep; 72(9):393-398. PubMed ID: 28892314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of sFlt-1/PlGF Ratio for Predicting and Improving Clinical Management of Pre-eclampsia: Experience in a Specialized Perinatal Care Center.
    Caillon H; Tardif C; Dumontet E; Winer N; Masson D
    Ann Lab Med; 2018 Mar; 38(2):95-101. PubMed ID: 29214752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol.
    Hund M; Allegranza D; Schoedl M; Dilba P; Verhagen-Kamerbeek W; Stepan H
    BMC Pregnancy Childbirth; 2014 Sep; 14():324. PubMed ID: 25230734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble fms-like tyrosine kinase-1, placental growth factor and their ratio as a predictor for pre-eclampsia in East Asians.
    Cheng YKY; Law LW; Leung TY; Chan OK; Sahota DS
    Pregnancy Hypertens; 2018 Jan; 11():61-65. PubMed ID: 29523275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Added prognostic value of longitudinal changes of angiogenic factors in early-onset severe pre-eclampsia: a prospective cohort study.
    Peguero A; Fernandez-Blanco L; Mazarico E; Benitez L; Gonzalez A; Youssef L; Crispi F; Hernandez S; Figueras F
    BJOG; 2021 Jan; 128(2):158-165. PubMed ID: 32593222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.